Sihuan Pharmaceutical Declares Final Cash Dividend for 2025

Sihuan Pharmaceutical Holdings Group ( (HK:0460) ) just unveiled an announcement.

Sihuan Pharmaceutical Holdings Group has declared a final ordinary cash dividend of RMB 0.0096 per share for the financial year ended 31 December 2025, with shareholders’ approval scheduled for 26 June 2026. The dividend will be paid in Hong Kong dollars at HKD 0.0109 per share, based on an exchange rate of RMB 1 to HKD 1.133, with an ex-dividend date of 30 June 2026 and payment set for 16 July 2026.

The company has outlined the key timetable for entitlement, including the last date to lodge share transfers on 2 July 2026, a book closure period from 3 to 6 July 2026, and a record date of 6 July 2026, with Tricor Investor Services acting as share registrar. The announcement signals Sihuan Pharmaceutical’s intention to return cash to shareholders, providing income to investors and potentially underscoring management’s confidence in its financial performance for 2025.

The most recent analyst rating on (HK:0460) stock is a Hold with a HK$1.50 price target. To see the full list of analyst forecasts on Sihuan Pharmaceutical Holdings Group stock, see the HK:0460 Stock Forecast page.

More about Sihuan Pharmaceutical Holdings Group

Sihuan Pharmaceutical Holdings Group Ltd. is a Hong Kong-listed pharmaceutical company, engaged in the development, manufacture, and sale of drug products. The group operates in the healthcare and life sciences sector, with its shares traded under stock code 00460 on the Hong Kong Stock Exchange, and is overseen by a board comprising executive and independent non-executive directors.

Average Trading Volume: 33,215,199

Technical Sentiment Signal: Buy

Current Market Cap: HK$12.69B

Learn more about 0460 stock on TipRanks’ Stock Analysis page.